SIV-specific neutralizing antibody induction following selection of a PI3K drive-attenuated nef variant
Abstract
HIV and simian immunodeficiency virus (SIV) infections are known for impaired neutralizing antibody (NAb) responses. While sequential virus-host B cell interaction appears to be basally required for NAb induction, driver molecular signatures predisposing to NAb induction still remain largely unknown. Here we describe SIV-specific NAb induction following a virus-host interplay decreasing aberrant viral drive of phosphoinositide 3-kinase (PI3K). Screening of seventy difficult-to-neutralize SIVmac239-infected macaques found nine NAb-inducing animals, with seven selecting for a specific CD8+ T-cell escape mutation in viral nef before NAb induction. This Nef-G63E mutation reduced excess Nef interaction-mediated drive of B-cell maturation-limiting PI3K/mammalian target of rapamycin complex 2 (mTORC2). In vivo imaging cytometry depicted preferential Nef perturbation of cognate Envelope-specific B cells, suggestive of polarized contact-dependent Nef transfer and corroborating cognate B-cell maturation post-mutant selection up to NAb induction. Results collectively exemplify a NAb induction pattern extrinsically reciprocal to human PI3K gain-of-function antibody-dysregulating disease, and indicate that harnessing the PI3K/mTORC2 axis may facilitate NAb induction against difficult-to-neutralize viruses including HIV/SIV.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Potent antibody-dependent cellular cytotoxicity of a V2-specific antibody is not sufficient for protection of macaques against SIV challenge
M. W. Grunst, H. M. Gil, … D. T. Evans·bioRxiv·Nov 14, 2023
- Rapid elicitation of a new class of neutralizing N332-glycan independent V3-glycan antibodies against HIV-1 in nonhuman primates.
Ignacio Relaño-Rodríguez, Jianqiu Du, … Amelia Escolano·bioRxiv·Sep 4, 2025
- Molecular insights into antibody-mediated protection against the prototypic simian immunodeficiency virus
F. Zhao, Z. T. Berndsen, … D. Sok·bioRxiv·Dec 22, 2021
- Control of SIV infection in prophylactically vaccinated, ART-naïve macaques is required for the most efficacious CD8 T cell response during treatment with the IL-15 superagonist N-803
A. L. Ellis-Connell, A. J. Balgeman, … S. L. O'Connor·bioRxiv·Jun 2, 2022
- Identification of a broad and potent V3 glycan site bNAb targeting anN332gp120 glycan-independent epitope
Lutz Gieselmann, Andrew T. DeLaitsch, … Florian Klein·bioRxiv·Sep 5, 2025
- Mucosal immune stimulation with HSV-2 and polyICLC boosts control of viremia in SIVΔNef vaccinated rhesus macaques with breakthrough SIV infection
M. Aravantinou, O. Mizenina, … N. Derby·bioRxiv·Jun 2, 2020